Bamco Inc Ptc Therapeutics, Inc. Transaction History

Bamco Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$37.95 - $49.37 $26.9 Million - $35 Million	-708,697 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$46.8 - $68.92 $8.96 Million - $13.2 Million	-191,413 Reduced 21.27%	708,697 $33.6 Million
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $2.61 Million - $3.68 Million	54,440 Added 6.44%	900,110 $54.9 Million
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $8.85 Million - $11.1 Million	194,823 Added 29.93%	845,670 $39.5 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $21.5 Million - $27.8 Million	506,302 Added 350.27%	650,847 $33 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $4.57 Million - $8.39 Million	141,270 Added 4313.59%	144,545 $6.45 Million
Q4 2019 Feb 18, 2020	BUY	$32.22 - $50.07 $105,520 - $163,979	3,275 New	3,275 $157,000

228

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.53B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.